Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
nference logo — Making biomedical knowledge computable

nference

Making biomedical knowledge computable

Founded 2013 United States Cambridge, United States 315 employees Total: $134.00M Biotechnology, Health Care +1

General Information

Company Name nference
Founded Year 2013
Location United States Cambridge, United States
Founders / Decision Makers
Team member
Employees 315
Industries Biotechnology, Health Care, Life Sciences
Business Model B2B, SaaS, DaaS
Revenue Model Data Monetization, Subscription, Service Fee
Offices as of Oct 2026
Cambridge, United States Bangalore, India Toronto, Canada Rochester, United States
Social

BounceWatch is an independent company data service, not affiliated with nference. To contact nference, visit nference.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does nference compare?

A PDF of nference and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting nference soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Growth Metrics Oct 07, 2026

nference's study on BPC-157 use found that quarterly newly documented users increased approximately 33-fold between 2020 and 2026.

Actively Hiring Oct 01, 2026

Hiring for 1 position in the last 30 days.

Get alerts when nference shows new signals

About nference

nference, founded in 2013, is driving innovation in the Biotechnology, Health Care, and Life Sciences sectors. Headquartered in the United States, nference specializes in transforming biomedical knowledge into computable insights, which aids in accelerating drug development, generating evidence, and improving clinical trials.

The company leverages its network of top academic minds and world-class researchers in conjunction with real-time, multimodal, patient-level data. Their flagship platform, nSights, delivers unparalleled biological and clinical insights to enhance patient care.

nference's last recorded investment was a Non Equity Assistance on 08 December 2022, with backing from PharmStars. Investors may find the company's advanced analytical capabilities and partnerships with leading researchers appealing, especially in an era increasingly reliant on data-driven healthcare solutions.

Business keywords: Biomedical Knowledge Computation, Drug Development Innovation, Clinical Trial Optimization, Multimodal Patient Data, Real-time Data Analysis, Personalized Medicine, Biological Insights, Clinical Insights, EMR Data Transformation, Biopharmaceutical Solutions, Patient-Centric Care, Academic Collaboration, Healthcare Ecosystem Integration, Evidence Generation

Services & Products

AI-powered clinical data analysis
Patient cohort design
Data annotation for model development
Advanced data science workbench
Translational science for ECG decoding

Target Customers

Clinical researchers Healthcare providers Pathology labs Medical centers Pharmaceutical companies

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Round Undisclosed 1
PharmStars
PharmStars
01 Dec 2022
Series C $60.00M 5
Matrix Partners Matrix Capital Management Mayo Clinic
Matrix Partners, Matrix Capital Management +3
01 Dec 2020
Series B $60.00M 4
Matrix Partners Matrix Capital Management Mayo Clinic
Matrix Partners, Matrix Capital Management +2
01 Jan 2020
Series A $11.00M 2
Matrix Partners Matrix Capital Management
Matrix Partners, Matrix Capital Management
01 Jun 2018
Seed $3.00M 2
Matrix Partners Matrix Capital Management
Matrix Partners, Matrix Capital Management
01 Jan 2016

nference Alternatives & Competitors

nference vs
Tempus AI
Tempus AI United States

Tempus AI, Inc. (NASDAQ: TEM) is a technology company leading the adoption of AI to advance precisio...

Post-IPO Debt
3178 employees
AI, Biotechnology
nference vs
CorEvitas, LLC
CorEvitas, LLC United States

Regulatory grade real-world evidence and clinical insights on post approval safety and effectiveness...

Private Equity
249 employees
Analytics, Biopharma
nference vs
Data4Cure, Inc.
Data4Cure, Inc. United States

Biomedical Intelligence. Turning data into cures.

Series A
30 employees
AI, Analytics

FAQ About nference

Making biomedical knowledge computable
nference was founded in 2013.
nference is headquartered in Cambridge, United States. As of Oct 2026, it also has offices in Bangalore, India, Toronto, Canada and Rochester, United States.
nference operates in Biotechnology, Health Care and Life Sciences. Its work centres on Biomedical Knowledge Computation, Drug Development Innovation, Clinical Trial Optimization and Multimodal Patient Data. Its customers include Clinical researchers, Healthcare providers and Pathology labs.
nference has a B2B, SaaS and DaaS business model. Its revenue comes from Data Monetization, Subscription and Service Fee.
nference has approximately 315 employees.
nference has completed 5 funding rounds, raising a total of $134.00M.
nference offers: AI-powered clinical data analysis, Patient cohort design, Data annotation for model development, Advanced data science workbench, Translational science for ECG decoding.
Top alternatives and competitors to nference include Tempus AI, CorEvitas, LLC, Data4Cure, Inc., Syntekabio Inc., 23Strands. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
nference and Tempus AI are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for nference, https://bouncewatch.com/company/nference-1, updated 26 October 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes